Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY 
    1.4 LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH APPROACH 
           2.1.1 SECONDARY SOURCES
                    2.1.1 .1 KEY DATA FROM SECONDARY SOURCES
           2.1.2 PRIMARY SOURCES
                    2.1.2.1 KEY DATA FROM PRIMARY SOURCES
                    2.1.2.2 BREAKDOWN OF PRIMARIES
                    2.1.2.3 KEY INDUSTRY INSIGHTS
    2.2 MARKET SIZE ESTIMATION 
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION  
    2.4 MARKET SHARE ESTIMATION 
    2.5 ASSUMPTIONS FOR THE STUDY 
    2.6 RISK ASSESSMENT 
    2.7 LIMITATIONS 
    2.8 RECESSION IMPACT ANALYSIS 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
    4.1 INFECTION CONTROL MARKET: OVERVIEW 
    4.2 ASIA PACIFIC: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE AND COUNTRY 
    4.3 INFECTION CONTROL MARKET: GEOGRAPHIC MIX 
    4.4 INFECTION CONTROL MARKET: REGIONAL MIX 
    4.5 INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 INDUSTRY TRENDS 
    5.4 VALUE CHAIN ANALYSIS 
    5.5 TECHNOLOGY ANALYSIS 
           5.5.1 KEY TECHNOLOGY
           5.5.2 COMPLEMENTARY TECHNOLOGY
           5.5.3 ADJACENT TECHNOLOGY
    5.6 PORTER'S FIVE FORCE ANALYSIS 
    5.7 REGULATORY LANDSCAPE  
           5.7.1 REGULATORY ANALYSIS
           5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION 
    5.8 PATENT ANALYSIS  
           5.8.1 PATENT PUBLICATION TRENDS FOR THE INFECTION CONTROL MARKET
           5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    5.9 TRADE ANALYSIS  
    5.10 PRICING ANALYSIS  
           5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.10.2 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY REGION
    5.11 REIMBURESEMENT ANALYSIS 
    5.12 KEY CONFERENCES & EVENTS DURING 2024-2025 
    5.13 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
           5.13.2 BUYING CRITERIA
    5.14 UNMET NEEDS IN INFECTION CONTROL MARKET 
    5.15 END USER EXPECTATIONS IN INFECTION CONTROL MARKET 
    5.16 AI INTEGRATION IN INFECTION CONTROL MARKET 
    5.17 ECOSYSTEM MARKET MAP  
    5.18 CASE STUDY ANALYSIS  
    5.19 SUPPLY CHAIN ANALYSIS  
    5.20 ADJACENT MARKET ANALYSIS 
    5.21 INFECTION CONTROL MARKET, INVESTMENT AND FUNDING SCENARIO 
6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021-2029 (USD MILLION) 
    6.1 INTRODUCTION 
    6.2 STERILIZATION PRODUCTS & SERVICES 
           6.2.1 STERILIZATION EQUIPMENT
                    6.2.1.1 HEAT STERILIZATION EQUIPMENT
                               6.2.1.1.1 MOIST HEAT STERILIZERS
                               6.2.1.1.2 DRY HEAT STERILIZERS
                    6.2.1.2 LOW-TEMPERATURE STERILIZATION
                               6.2.1.2.1 HYDROGEN PEROXIDE STERILIZATION
                               6.2.1.2.2 ETHYLENE OXIDE (ETO) STERILIZATION
                               6.2.1.2.3 FORMALDEHYDE STERILIZATION
                               6.2.1.2.4 OTHER LOW-TEMPERATURE STERILIZATION PRODUCTS
                    6.2.1.3 RADIATION STERILIZATION
                    6.2.1.4 FILTRATION STERILIZATION EQUIPMENT
                    6.2.1.5 OTHER STERILIZATION EQUIPMENT
           6.2.2 CONTRACT STERILIZATION SERVICES MARKET
                    6.2.2.1 ETO STERILIZATION SERVICES
                    6.2.2.2 GAMMA STERILIZATION SERVICES
                    6.2.2.3 E-BEAM STERILIZATION SERVICES
                    6.2.2.4 STEAM STERILIZATION SERVICES
                    6.2.2.5 OTHER CONTRACT STERILIZATION SERVICES
    6.3 CONSUMABLES & ACCESSORIES 
           6.3.1 STERILIZATION INDICATORS
                    6.3.1.1 CHEMICAL INDICATORS
                    6.3.1.2 BIOLOGICAL INDICATORS
           6.3.2 STERILIZATION POUCHES
           6.3.3 STERILIZATION LUBRICANTS
           6.3.4 STERILIZATION ACCESSORIES
    6.4 CLEANING & DISINFECTION PRODUCTS 
           6.4.1 DISINFECTANTS
                    6.4.1.1 DISINFECTANTS, BY PRODUCT TYPE
                               6.4.1.1.1 HAND DISINFECTANTS
                               6.4.1.1.2 SURFACE DISINFECTANTS
                               6.4.1.1.3 SKIN DISINFECTANTS
                               6.4.1.1.4 INSTRUMENT DISINFECTANTS
                    6.4.1.2 DISINFECTANTS, BY FORMULATION
                               6.4.1.2.1 LIQUID DISINFECTANTS
                               6.4.1.2.2 DISINFECTANT WIPES
                               6.4.1.2.3 DISINFECTANT SPRAYS
                    6.4.1.3 DISINFECTANTS, BY EPA CLASSIFICATION
                               6.4.1.3.1 LOW-LEVEL DISINFECTANTS
                               6.4.1.3.2 INTERMEDIATE-LEVEL DISINFECTANTS
                               6.4.1.3.3 HIGH-LEVEL DISINFECTANTS
           6.4.2 CLEANING & DISINFECTION EQUIPMENT
                    6.4.2.1 WASHER DISINFECTORS
                    6.4.2.2 FLUSHER DISINFECTORS
                    6.4.2.3 UV-RAY DISINFECTORS
                    6.4.2.4 ULTRASONIC CLEANERS
                    6.4.2.5 OTHER CLEANING & DISINFECTION EQUIPMENT
           6.4.3 LUBRICANTS & CLEANING SOLUTIONS
           6.4.4 DISINFECTION & CLEANING ACCESSORIES
    6.5 PROTECTIVE BARRIERS 
           6.5.1 MEDICAL NONWOVENS
                    6.5.1.1 FACE MASKS
                    6.5.1.2 SURGICAL GOWNS
                    6.5.1.3 SURGICAL DRAPES
           6.5.2 GLOVES
           6.5.3 COVERS & CLOSURES
           6.5.4 GOGGLES
    6.6 ENDOSCOPE REPROCESSING PRODUCTS 
           6.6.1 ENDOSCOPE REPROCESSING CONSUMABLES
           6.6.2 ENDOSCOPE REPROCESSING EQUIPMENT
                    6.6.2.1 AUTOMATED ENDOSCOPE REPROCESSORS
                    6.6.2.2 ENDOSCOPE TRACKING SYSTEMS
           6.6.3 OTHER ENDOSCOPE REPROCESSING PRODUCTS
    6.7 OTHER INFECTION CONTROL PRODUCTS 
7 INFECTION CONTROL MARKET, BY END USER, 2021-2029 (USD MILLION) 
    7.1 INTRODUCTION 
    7.2 HOSPITALS & CLINICS 
    7.3 MEDICAL DEVICE COMPANIES 
    7.4 PHARMACEUTICAL COMPANIES 
    7.5 LIFE SCIENCE INDUSTRY 
    7.6 FOOD INDUSTRY 
    7.7 OTHER END USERS 
8 INFECTION CONTROL MARKET, BY REGION, 2021-2029 (USD MILLION) 
    8.1 INTRODUCTION 
    8.2 NORTH AMERICA 
           8.2.1 RECESSION IMPACT
           8.2.2 US 
           8.2.3 CANADA
    8.3 EUROPE 
           8.3.1 RECESSION IMPACT
           8.3.3 GERMANY 
           8.3.4 UK
           8.3.5 FRANCE
           8.3.6 SPAIN
           8.3.7 ITALY
           8.3.8 SWITZERLAND
           8.3.9 REST OF EUROPE
    8.4 ASIA PACIFIC 
           8.4.1 RECESSION IMPACT
           8.4.2 JAPAN
           8.4.3 CHINA
           8.4.4 INDIA
           8.4.5 AUSTRALIA
           8.4.6 SOUTH KOREA
           8.4.7 REST OF ASIA PACIFIC
    8.5 LATIN AMERICA 
           8.5.1 RECESSION IMPACT
           8.5.2 BRAZIL
           8.5.3 MEXICO
           8.5.4 REST OF LATIN AMERICA
    8.6 MIDDLE EAST & AFRICA 
           8.6.1 RECESSION IMPACT
    8.7 GCC COUNTRIES 
           8.7.1 RECESSION IMPACT
9 COMPETITIVE LANDSCAPE 
    9.1 OVERVIEW 
    9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
    9.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS  
    9.4 MARKET SHARE ANALYSIS 
           9.4.1 STERILIZATION PRODUCTS & SERVICES MARKET 
           9.4.2 SURFACE DISINFECTANTS MARKET 
           9.4.3 ENDOSCOPE REPROCESSING MARKET 
    9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023  
           9.5.1 STARS 
           9.5.2 EMERGING LEADERS
           9.5.3 PERVASIVE PLAYERS
           9.5.4 PARTICIPANTS
           9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                    9.5.5.1 COMPANY FOOTPRINT
                    9.5.5.2 REGION FOOTPRINT
                    9.5.5.3 PRODUCT & SERVICE FOOTPRINT
                    9.5.5.4 END USER FOOTPRINT
    9.6 COMPANY EVALUATION MATRIX: START-UPS/SMEs, 2023  
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 RESPONSIVE COMPANIES
           9.6.3 DYNAMIC COMPANIES
           9.6.4 STARTING BLOCKS
           9.6.5 COMPETITIVE BENCHMARKING
                    9.6.5.1 DETAILED LIST OF KEY START-UPS/SMEs
                    9.6.5.1 COMPETITIVE BENCHMARKING OF START-UPS/SMEs
    9.7 COMPETITIVE SCENARIO 
           9.7.1 PRODUCT LAUNCHES
           9.7.2 DEALS
           9.7.3 EXPANSIONS
           9.7.4 OTHER DEVELOPMENTS
    9.8 INFECTION CONTROL MARKET, INVESTMENT LANDSCAPE 
    9.9 INFECTION CONTROL MARKET, BRAND/PRODUCT COMPARATIVE ANALYSIS 
10 COMPANY PROFILES 
     10.1 KEY PLAYERS 
             10.1.1 STERIS (US)
             10.1.2 GETINGE (SWEDEN)
             10.1.3 ECOLAB (US)
             10.1.4 3M COMPANY (US)
             10.1.5 ADVANCED STERILIZATION PRODUCTS (US)
             10.1.6 SOTERA HEALTH COMPANY (US)
             10.1.7 MMM GROUP (GERMANY)
             10.1.8 MATACHANA GROUP (SPAIN)
             10.1.9 BELIMED (SWITZERLAND)
             10.1.10 METREX RESEARCH (US)
             10.1.11 RECKITT BENCKISER (UK)
             10.1.12 PAL INTERNATIONAL (UK)
             10.1.13 MELAG MEDIZINTECHNIK (GERMANY)
             10.1.14 THE MIELE GROUP (GERMANY)
             10.1.15 SYSTEC (GERMANY)
             10.1.16 CONTEC (US)
             10.1.17 CONTINENTAL EQUIPMENT COMPANY (US) 
             10.1.18 MEDALKAN (GREECE)
             10.1.19 C.B.M. S.R.L. MEDICAL EQUIPMENT (ITALY)
             10.1.20 SPIRE INTEGRATED SOLUTIONS (US)
     10.2 OTHER PLAYERS  
             10.2.1 DR. SCHUMACHER GMBH (GERMANY)
             10.2.2 ACTO GMBH (GERMANY)
             10.2.3 CONSOLIDATED STERILIZER SYSTEMS (US)
             10.2.4 ULTRAWAVE (UK)
             10.2.5 ARC HEALTHCARE SOLUTIONS (CANADA)
11 APPENDIX 
     11.1 INSIGHTS OF INDUSTRY EXPERTS 
     11.2 DISCUSSION GUIDE 
     11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     11.4 AVAILABLE CUSTOMIZATION 
     11.5 RELATED REPORTS 
     11.6 AUTHOR DETAILS  
*The segmentation of the study can be updated during the course of the study based on primary insights and secondary research
*The list of companies mentioned above is indicative only and might change during the course of the study.
*Details on key financials might not be captured in the case of unlisted companies.